Team-based care approach to cholesterol management in diabetes mellitus: 2-Year cluster randomized controlled trial

Archives of Internal Medicine

Volumn 171, Issue 16, 2011, Pages 1480-1486

  Pape, Ginger A ^a   Hunt, Jacquelyn S ^b   Butler, Kristina L ^c   Siemienczuk, Joseph ^a   LeBlanc, Benjamin H ^a   Gillanders, William ^a   Rozenfeld, Yelena ^a   Bonin, Kerry ^a  

^a Providence Medical Group   (United States)

^b Bellin Health   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; PATIENT SATISFACTION; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TEAM NURSING;

AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; COOPERATIVE BEHAVIOR; DIABETES MELLITUS; FEMALE; HEALTH CARE SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OREGON; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACISTS; PHYSICIANS; TREATMENT OUTCOME;

EID: 80052711467     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.417     Document Type: Article

References (22)

1. Running a practice: patient-centered medical home (PCMH). American Academy of Family Practice Web site. http://www.aafp.org/online/en/home/ membership/initiatives/pcmh.html. Accessed April 21, 2010.
2. AAFP Initiatives: health care system reform: principles for reform of the US health care system. American Academy of Family Practice Web site. http://www.aafp.org/online/en/home/membership/initiatives/hrsprinciples.html. Accessed April 21, 2010.
3. American Recovery and Reinvestment Act of 2009, HR 1, 111th Cong, 1st Sess (2009).
4. Cusak C, Knudson A, Kronstadt J, Singer R, Brown A. Practice-Based Population Health: Information Technology to Support Transformation to Proactive Primary Care (Prepared for the AHRQ National Resource Center for Health Information Technology under Contract No. 290-04-0016). Rockville, MD: Agency for Healthcare; 2010:24-25. AHRQ Pub No. 10-0092-EF.
5. Population-wide chronic care management. http://www.kryptiq.com/ solutions/patient-engagement/caremanager/. Kryptiq Corp Web site. Accessed May 2010.
6. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ. 2003;327(7418):785-789.
7. Edwards SJ, Braunholtz DA, Lilford RJ, Stevens AJ. Ethical issues in the design and conduct of cluster randomised controlled trials. BMJ. 1999;318(7195): 1407-1409. (Pubitemid 29237838)
8. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. London, England: Hodder Arnold Pub; 2000.
9. London A. Deprivation, disease, and the ethics of international research. Bioeth Exam. 2000;4(1):1-, 4.
10. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979;300(22): 1242-1245. (Pubitemid 9236327)
11. Zelen M. Strategy and alternate randomized designs in cancer clinical trials. Cancer Treat Rep. 1982;66(5):1095-1100. (Pubitemid 12090370)
12. Hunt JS, Siemienczuk J, Gillanders W, et al. The impact of a physician-directed health information technology system on diabetes outcomes in primary care: a pre- and post-implementation study. Inform Prim Care. 2009;17(3):165-174.
13. Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010; 48(10):923-933.
14. Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of teambased care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23(12):1966-1972.
15. Olson KL, Rasmussen J, Sandhoff BG, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Arch Intern Med. 2005;165(1):49-54.
16. Montori VM, Bjornsen SS, Green EM, et al. Performance of the provider recognition program's survey to assess patient satisfaction with the provision of diabetes care in primary care. Am J Manag Care. 2002;8(4):365-372. (Pubitemid 34406536)
17. SAS Institute Inc. SAS/STAT User's Guide, Version 9.1. Cary, NC: SAS Institute Inc; 2003.
18. Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG; Clinical Pharmacy Cardiac Risk Service Study Group. Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease. Pharmacotherapy. 2007;27(10):1370-1378.
19. Straka RJ, Taheri R, Cooper SL, Smith JC. Achieving cholesterol target in a managed care organization (ACTION) trial. Pharmacotherapy. 2005;25(3):360-371. (Pubitemid 40300323)
20. Bogden PE, Koontz LM, Williamson P, Abbott RD. The physician and pharmacist team: an effective approach to cholesterol reduction. J Gen Intern Med. 1997;12(3):158-164. (Pubitemid 27180568)
21. Mazzolini TA, Irons BK, Schell EC, Seifert CF. Lipid levels and use of lipidlowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers. J Manag Care Pharm. 2005;11(9):763-771.
22. Fabbio KL, Bradley M, Chrymko M. Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center. Ann Pharmacother. 2010;44(1):50-56.